首页> 外国专利> Therapy-infusion solution, preferably e.g. macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution and Parkinson's therapy-infusion solution, comprises hydroxyethyl acid based solution and Ginkgo biloba

Therapy-infusion solution, preferably e.g. macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution and Parkinson's therapy-infusion solution, comprises hydroxyethyl acid based solution and Ginkgo biloba

机译:治疗输注溶液,优选例如黄斑变性治疗输液,多发性神经病治疗输液和帕金森氏治疗输液,包括基于羟乙基酸的溶液和银杏叶

摘要

Therapy-infusion solution, preferably macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution, Parkinson's therapy-infusion solution, multiple sclerosis therapy-infusion solution or Alzheimer's therapy-infusion solution, comprises a basic solution, preferably hydroxyethyl acid based solution and Ginkgo biloba. An independent claim is also included for Ginkgo biloba, preferably an extract from a plant of Ginkgo biloba, as a drug for treating macular degeneration, polyneuropathy, Parkinson's disease, multiple sclerosis, or dementia, preferably Alzheimer's disease. ACTIVITY : Ophthalmological; Neuroprotective; Nootropic; Antiparkinsonian. No biological data given. MECHANISM OF ACTION : None given.
机译:治疗输注溶液,优选黄斑变性治疗输注溶液,多发性神经病治疗输注溶液,帕金森氏治疗输注溶液,多发性硬化症治疗输注溶液或阿尔茨海默氏治疗输注溶液,包括碱性溶液,优选羟乙基酸基溶液和银杏。比洛巴。还包括银杏叶的独立权利要求,优选为来自银杏叶植物的提取物,作为用于治疗黄斑变性,多发性神经病,帕金森氏病,多发性硬化或痴呆的药物,优选阿尔茨海默氏病。活动:眼科;具有神经保护作用;促智;反帕金森人。没有给出生物学数据。作用机理:未给出。

著录项

  • 公开/公告号DE102012002428A1

    专利类型

  • 公开/公告日2012-08-16

    原文格式PDF

  • 申请/专利权人 PRIES WOLFGANG;

    申请/专利号DE20121002428

  • 发明设计人 PRIES WOLFGANG;

    申请日2012-02-09

  • 分类号A61K36/16;A61K31/715;

  • 国家 DE

  • 入库时间 2022-08-21 17:04:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号